Shrewsbury, NJ, United States of America

Marcia M Zweerink

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcia M Zweerink. Retrieved from https://idiyas.com/inventor/marcia-m-zweerink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Marcia M Zweerink**

Introduction

Marcia M Zweerink, an accomplished inventor based in Shrewsbury, NJ, has made significant strides in the field of biotechnology. With her innovative mindset, she has developed a patented antibiotic agent that showcases her commitment to advancing medical solutions.

Latest Patents

Marcia holds a patent for an antibiotic agent produced by the cultivation of Dictyochaeta simplex. This compound demonstrates broad antifungal activity and is effective against pneumocystis, highlighting its potential in treating serious infections and improving patient outcomes.

Career Highlights

Marcia M Zweerink works at Merck & Company, Inc., a leading global pharmaceutical company. Her work there underscores her dedication to research and development in the pharmaceutical industry, contributing to the advancement of healthcare solutions.

Collaborations

In her pursuit of innovation, Marcia has collaborated with esteemed colleagues, including George M Garrity and Sagrario M Del Val. These partnerships have likely fostered a creative environment, enhancing the development of effective therapeutic agents.

Conclusion

Marcia M Zweerink's contributions to the field of biotechnology through her innovative antibiotic agent reflect her expertise and dedication. Her work at Merck & Company, combined with her collaborations, positions her as an influential figure in the ongoing quest for effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…